DOLs

Digital

Pharma companies are turning to digital opinion leaders (DOLs) to fight misconceptions, raise disease awareness, and promote their products.

News

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.